Analyst consensus rating
Estrella Immunopharma Analyst Rating: Strong Buy
Direct answer
Estrella Immunopharma's consensus rating is Strong Buy.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $12.00.
Forecast evidence checked September 5, 2026.
Get free Estrella Immunopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.65
- Average price target
- $12.00
- High price target
- $12.00
- Low price target
- $12.00
- Low target gap
- +1,756.7%
- Target upside
- +1,756.7%
- High target gap
- +1,756.7%
- Target range width
- 0%
- Consensus rating
- Strong Buy
- Analysts
- 1
- Evidence date
- September 5, 2026
- Valid through
- September 12, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Estrella Immunopharma?
Estrella Immunopharma has a verified Strong Buy consensus. The same dataset has an average price target of $12.00.
How far are Estrella Immunopharma's low and high targets from the recorded price?
The low target implies +1,756.7%, while the high target implies +1,756.7%.
How many analysts are included in Estrella Immunopharma's consensus?
The verified consensus includes 1 analysts.
How is Estrella Immunopharma's target upside or downside calculated?
The average target of $12.00 is divided by the recorded price of $0.65, then one is subtracted to produce +1,756.7%. This does not guarantee a future return.
When was Estrella Immunopharma's analyst forecast verified?
The data was verified on 2026-09-05. The dataset is valid through 2026-09-12.